Patients for Biologics Safety & AccessCost Not Part of FDA Mandate When Considering Biosimilar ApprovalBy Paul Gileno, US Pain FoundationJul 8, 2016Jul 8, 2016
Patients for Biologics Safety & Access6 Recommendations as FDA Considers New Biosimilar ApprovalsBy Larry LaMotteJul 6, 2016Jul 6, 2016
Patients for Biologics Safety & AccessBiosimilars 101: The Facts on New Biologic DrugsBy Larry LaMotteJun 7, 2016Jun 7, 2016